Showing results (81-90 of 142) with videos related to
Sort By:
Pageof 15
Thrombosis Research|February 27, 2016
Urgent surgery or procedures in patients taking dabigatran or warfarin: Analysis of perioperative outcomes from the RE-LY trialJames D Douketis, Jeff S Healey, Martina Brueckmann, et al.Circulation|January 5, 2011
Dabigatran versus warfarin in patients with atrial fibrillation: an analysis of patients undergoing cardioversionRangadham Nagarakanti, Michael D Ezekowitz, Jonas Oldgren, et al.Journal of the American Heart Association|January 18, 2019
Cardiac Biomarkers and Left Ventricular Hypertrophy in Relation to Outcomes in Patients With Atrial Fibrillation: Experiences From the RE - LY TrialZiad Hijazi, Paolo Verdecchia, Jonas Oldgren, et al.American Heart Journal|March 30, 2013
Rate versus rhythm control for management of atrial fibrillation in clinical practice: results from the Outcomes Registry for Better Informed Treatment of Atrial Fibrillation (ORBIT-AF) registryBenjamin A Steinberg, DaJuanicia N Holmes, Michael D Ezekowitz, et al.Circulation. Cardiovascular Quality and Outcomes|March 25, 2024
Estimating Vitamin K Antagonist Anticoagulation Benefit in People With Atrial Fibrillation Accounting for Competing Risks: Evidence From 12 Randomized TrialsSachin J Shah, Carl van Walraven, Sun Young Jeon, et al.Lancet (London, England)|August 31, 2010
Efficacy and safety of dabigatran compared with warfarin at different levels of international normalised ratio control for stroke prevention in atrial fibrillation: an analysis of the RE-LY trialLars Wallentin, Salim Yusuf, Michael D Ezekowitz, et al.Journal of the American Heart Association|December 9, 2020
Screening of Multiple Biomarkers Associated With Ischemic Stroke in Atrial FibrillationZiad Hijazi, Lars Wallentin, Johan Lindbäck, et al.Cardiovascular Research|August 6, 2021
Using multimarker screening to identify biomarkers associated with cardiovascular death in patients with atrial fibrillationTymon Pol, Ziad Hijazi, Johan Lindbäck, et al.Lancet (London, England)|December 10, 2013
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trialsChristian T Ruff, Robert P Giugliano, Eugene Braunwald, et al.Circulation|August 30, 2016
Performance and Validation of a Novel Biomarker-Based Stroke Risk Score for Atrial FibrillationJonas Oldgren, Ziad Hijazi, Johan Lindbäck, et al.Pageof 15